xml version="1.0" encoding="UTF-8"?        Document  

false0001071739  0001071739   2020-01-14 2020-01-14  

UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION 

WASHINGTON, D.C. 20549 

FORM 8-K 

CURRENT REPORT 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 

Date of Report (Date of earliest event reported): January 14, 2020 

CENTENE CORPORATION 

(Exact Name of Registrant as Specified in Charter) 

[DATA_TABLE_REMOVED]

[DATA_TABLE_REMOVED]

Registrant’s telephone number, including area code: (314) 725-4477 

(Former Name or Former Address, if Changed Since Last Report): N/A

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): 

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐ 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ 

Securities registered pursuant to Section 12(b) of the Act:

[DATA_TABLE_REMOVED]

ITEM 8.01 OTHER EVENTS

On January 14, 2020, Centene Corporation (the “Company”) announced the extension of the expiration date of the offers to exchange (the “Exchange Offers”) notes (the “WellCare Notes”) issued by WellCare Health Plans, Inc. (“WellCare”) for up to $1,950,000,000 aggregate principal amount of new notes to be issued by the Company and cash and the related consent solicitations being made by the Company on behalf of WellCare to adopt certain proposed amendments to the indentures governing the WellCare Notes. The Company extended such expiration date from 5:00 p.m., New York City time, on January 14, 2020 to 5:00 p.m. 5:00 p.m., New York City time, on January 21, 2020 (as the same may be further extended). On November 14, 2019, requisite consents were received and supplemental indentures were executed, eliminating substantially all restrictive covenants and certain events of default and other provisions in each of the indentures governing the WellCare Notes. Such supplemental indentures will only become operative upon the settlement date of the Exchange Offers. A copy of the press release is attached hereto as Exhibit 99.1, and is incorporated into this Item 8.01 by reference. 

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS

(d) Exhibits.

EXHIBIT INDEX

[DATA_TABLE_REMOVED]

SIGNATURE 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. 

[DATA_TABLE_REMOVED]